Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Minoxidil can reduce functions related to androgen receptors.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Hair loss gene linked to prostate issues.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Unripe Rubus occidentalis extracts may help treat benign prostatic hyperplasia.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

ERG increases SOX9, promoting prostate cancer growth and invasion.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Gut bacteria can lower androgen levels in male mice.